Health

Plastic surgeons in South Florida have been pushing for safer standards in the popular cosmetic procedure known as Brazilian butt lifts (BBLs) after a series of deaths prompted concerns about its safety. In response to these concerns, the Florida medical board and physician groups have collaborated to establish laws that codify the standards of care
0 Comments
A new drug called Eplontersen (Wainua) has recently been approved by the FDA for the treatment of polyneuropathy associated with hereditary transthyretin-mediated amyloidosis (ATTR) in adults. This approval comes as a significant breakthrough in the field of medicine, offering hope to the thousands of individuals affected by this condition. Hereditary ATTR is a genetic disorder
0 Comments
In a recent study conducted by Penn Medicine and published in the American Journal of Preventive Medicine, it was found that women who scheduled their own mammograms were more likely to complete the screening process. This finding highlights the importance of patient autonomy in healthcare. By allowing women to take control of their own health
0 Comments
Inflammatory bowel disease (IBD) and relapsing multiple sclerosis (RMS) are chronic conditions that can pose challenges for women who become pregnant. One such challenge is the use of sphingosine-1-phosphate (S1P) receptor modulators like ozanimod. While there have been warnings about the potential risks associated with taking ozanimod during pregnancy, recent research suggests that these concerns
0 Comments
The decision to attempt vaginal delivery or opt for a repeat cesarean section can be challenging for women who have previously undergone a cesarean delivery. The Canadian PRISMA trial aimed to determine whether an intervention aimed at supporting decision-making could reduce perinatal and maternal morbidity in this population. The study found that the intervention group
0 Comments
In 2003, two former opposing political leaders, Tom Daschle and Bill Frist, joined forces to support President George W. Bush in authorizing the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). This decision was made at a time when the global AIDS crisis was reaching catastrophic levels. Despite their political differences, Daschle and Frist recognized
0 Comments
The recent FDA approval of the postpartum depression (PPD) pill zuranolone (Zurzuvae) marks a significant scientific achievement. This novel treatment, along with the IV infused brexanolone (Zulresso), is the only psychopharmacological interventions approved specifically for PPD. The development of these drugs, which target allopregnanolone and modulate the GABAA receptor, shows promising results in improving symptoms
0 Comments